Observational studyBMC pregnancy and childbirth2025
The impact of SARS-CoV-2 infection on vaccinated versus unvaccinated pregnant women: a retrospective cohort study.
Observational study in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesPregnant women were included in the COVID-19 vaccination strategy adopted in Spain in May 2021. We evaluated the obstetric and neonatal symptoms and complications presented by these first pregnant women infected with SARS-CoV-2, vaccinated and unvaccinated.
methodsA retrospective observational cohort study of 156 pregnant women with a positive diagnosis of SARS-CoV-2 (infection rate of 4.2%, 156/3719 births), treated at two public hospitals in the Valencian Community (Spain) over two years (2020-2022). Of those pregnant women infected, 28.8% (45) had received at least one dose of the COVID-19 vaccine before infection. The data were obtained from the digital medical record, the Nominal Vaccination Registry (RNV), and symptom data from the Epidemiological Surveillance Application (AVE) of the CV, supervised by the epidemiology units. We analyzed the symptoms of the disease and the main obstetric and neonatal variables depending on whether or not they were vaccinated with mRNA vaccines.
resultsMost pregnant women were diagnosed in the third trimester of pregnancy (p = 0.003) and reported symptoms associated with the infection (73%), but vaccinated women reported all the symptoms described to a lesser extent, with headache (R1.38, 95%IC 1.15 to 1.66) and vomiting (R 1.38, 95%IC 1.15 to 1.66) statistically significant. All cases of pneumonia occurred in unvaccinated pregnant women who required ventilatory assistance and referral to the Intensive Care Unit. Pregnant women vaccinated against SARS-CoV-2 infection had lower rates of gestational pathology, milder symptoms, and fewer postpartum complications than unvaccinated women, although the small sample size did not allow for a significant difference to be seen. Neonatal outcomes were similar in both groups.
conclusionsCOVID-19 vaccination in pregnant women with at least one dose is associated with reduced symptoms, less headache and vomiting, and fewer maternal complications, including pneumonia, which did not occur in the vaccinated cohort. Furthermore, the Apgar score at one and five minutes is higher than 7 in children of immunized mothers.Public health strategies should promote access to vaccines during pregnancy as an urgent priority, to minimize the risk of complications from COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.